Therefore, this study aimed to assist in predicting HER2‐low breast cancer via multimodal ultrasound imaging and clinicopathological indicators, providing valuable imaging information for clinical diagnosis and prognosis evaluation. The gene discussed is ERBB2; the disease is breast carcinoma.